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Aims and Objectives
The in-vitro meat (IVM) research field remains small with perhaps 50 or so scientists active
globally. These scientists are in the Netherlands, the US, the UK, Sweden, Israel and Norway,
with some interest expressed in Denmark and by a group of bioreactor engineers in Portugal.
The main groups involved in supporting this innovation domain are: New Harvest, a US based
pro-IVM campaign group that raises funds through donations for small scale research work,
discusses IVM in the media and organises conference panels; the In-Vitro Meat Consortium,
established by Dutch and Norwegian scientists in 2008 as a networking device with presence at
conferences, although, now with limited activity; the  US animal rights group People for the
Ethical Treatment of Animals (PETA). The most high profile laboratories are those of Mark
Post at Maastricht University and the New York based private company Modern Meadow, both
of which have become relatively financially secure research sites over the last three years. 
The  aim  of  the  Epinet  case  study  was  to  explore  and  interact  with  these  epistemic
communities / networks that have been developing, implementing, supporting and promoting
IVM  technologies.  The  study  team  consisted  of  expertise  in  sociotechnical  evaluations,
systems and uncertainty analysis, ethics and media studies. The team identified early on a small
set of policy considerations around the issues of  public funding  and  the social shaping of
IVM. The question of whether or not IVM research should be publicly funded has had to be
viewed in relation to how IVM technologies are represented, understood, shaped and reshaped
and,  accordingly,  what  sort  of  IVM  activities  should  be  funded.  When  the  case  study
commenced in 2012, government policy makers had only twice chosen to fund IVM laboratory
work, i.e., a section of the Dutch government interested in environmental issues and protein
(2005-2009;  2010-2014),  and  NASA (~2000).  In  addition  to  that,  the  European  Science
Foundation (ESF) funded a two day blue skies conference in Gothenburg, Sept. 2011. Other
funders include PETA, New Harvest, and private donators.
The policy considerations presented here have served throughout the case study as a common
point of reference in dialogue across the network of IVM research and evaluation. As it stands,
basic research into IVM is focussed upon cell-culturing techniques, but if the technology is to
flourish  it  will  have  to  scale-up  and  recreate  the  laboratory  work  of  cell-culturing  on  an
industrial mass scale. While a scaling of that nature is not yet a foreseeable future, the case
study was developed to reflect upon the early stage technology-readiness of what remains an
emergent science in search of funding, in search of users, in search of identity.
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Research questions that shaped the course of the case study:
Who is involved in IVM, why and how did they become active?
How do they interact as an epistemic network?
What role do politically engaged activist groups play in shaping the emergent biotechnology?
How do IVM protagonists establish a shared imaginary of its future large-scale application, its use and 
its users?
How is this imaginary materialised and what actions, both in terms of product design and discursive 
promotion, are undertaken that expand the epistemic network?
How do the scientists, positioned as insiders or outsiders of mainstream biomedical tissue engineering, 
frame their work and capacity in the area?
How do imagined future regulatory hurdles shape IVM work?
Policy considerations and recommendations
Our central policy considerations are presented here as discussion points, directed at scientific
and  innovation  policy  advisory  bodies to  the  European  Sceince  Foundation  (ESF),  DG-
Research  and  other  relevant  EC  Directorates  and  national  research  funds  in  matters  of
agriculture  and  food  policy,  biotechnology,  food  security  the  environment  and  sustainable
industries.
(1) How  is  IVM conceived  of  and  the  research  contextualised?  Supporting  pathways
from laboratory cell-culturing into food development.
Explanation/findings:  We  observe  inconsistencies  in  the  definition  of  IVM  as  an
innovation object,  and in the  framing of  its  place  and purpose  in  the world .  It  is
unclear what this particular innovation is for. If it is a solution to something, then it is
unclear what exactly the problem is. We observe arguments that seemingly justify the
eventual  IVM  innovation,  that  it  will  target  environmental  problems  linked  to  meat
production  and  over  consumption.  However,  these  arguments  find  their  way  into
contradictory narratives when they are presented, for example, in conjunction with ideas
about new niche markets and in related developments that are likely to reinforce not
solve current problems linked to overproduction. In other words, the low priority given to
the  IVM  research  field  by  public  funding  organisations  and  in  innovation  policy
development is explained, in part at least, by 'unconvincing' sociotechnical imaginaries
presented by the IVM research community and its supporters. Policy-makers will need to
know what IVM is and the problems it is targeting before they can talk about developing
an innovation policy.
Recommendation : An innovation policy regarding IVM research and development towards
food production, needs to reach clarity on the 'problem/solution' definitions and framing of
IVM and of IVM research elements.
(2) How does IVM research attract attention and what kind of attention does it get?
Explanation/findings:  We  observe  that  the  IVM  network  has  underestimated  the
importance of the fact  that meat  is  not just  'animal muscle tissue'  but  an entity that
attracts attention for a whole range of reasons other than possible ecological, ethical
and industrial advantages. For example, we observed through focus group research that
IVM is largely perceived as artificial and the artificiality of food products is typically
seen in a negative light. This reaction indicates to us unease with IVM as a product or an
ingredient in products that will be found in the marketplace in the future. However, as
regards the media attention IVM has received, we observe mixed narratives of curiosity,
awe and rejection, and also that so-called 'promotional publics' can be invoked by a big
media event such as the cultured burger launch in 2013.2 The outcome of this media
event suggests to us a way to think productively about the mix of public engagement with
PR and advertising as integral to the making of technoscience (here IVM), while the
dominant tendency is perhaps to dismiss PR and advertising as superficial and cynical,
biased and irresponsible.
Policy consideration (general for innovation policy): To what extent should policy-makers
take on board  PR and marketing –  occurring 'upstream' in  research and innovation – as
constructive elements of public engagement and deliberation?
2 Kate O’Riordan, Aristea Fotopoulou and Neil Stephens (under review). 'The first bite: imaginaries of food, 
publics and the laboratory grown burger.' Public Understanding of Science.
2
 (3) The  social  acceptance  hurdles  in  transforming  IVM  technologies  into  food
development, possibly large-scale industrial production
Explanation/findings: We observe that the IVM network has underestimated the wide
range of cultural and social meanings attached to meat, its production and consumption,
leaving it an open question:  What 'is' IVM? For example, they have been unprepared
for the so-called 'yuck' factor and how to make sense of it. They have not been prepared
for its persistence despite the work done to move beyond it, or to expect persistent social
rejection on the basis of the artificiality of IVM, although, this is in accordance with past
experiences of artificial foods innovations. It is also of some concern how an impressive
technical ability finds itself here in search of purpose, of social support, acceptance and
justification. In that respect, IVM is like a toy in want of a convincing social argument. It
remains a rather vague idea of a product, however, a product looking for a market which
risks being open to all arguments (good or bad) in favour of IVM developments, i.e., if it
is enough to justify monetary investment. Policy-makers will need to know if they are
looking at developing innovation policy or marketing strategies. Although the two are
now  inextricably  linked  in  the  H2020  programme,  the latter  (developing  marketing
strategies)  may  be  at  odds  with  the  social  and  common-good  logic  we  expect  from
innovation policy.
Recommendation:  An innovation policy regarding IVM research and development towards
food production, needs to reach clarity on the reasons for why IVM products are socially
and culturally contentious,  and on the  extent  to  which  marketing  logics  are  allowed to
dictate the justifications to move forward.
(4) The  implementation  hurdles  in  transforming  IVM  technologies  into  food
development, possibly large-scale industrial production
Explanation/findings:  We  observe  that  the  IVM  network  has  underestimated  the
structural and systemic challenges that would have to be met if IVM were to be scaled up
to industrial level. In particular, the network has not appreciated the enormous challenge
it would pose to attempt an integration of mass-scale IVM production into the existing
agri-food  system.  In  spite  of  some  appealing  arguments  about  reduced  energy
consumption,  land use and climate gas emissions,  IVM still  risks being perceived as
impracticable  and unappealing  from the  point  of  view of  production  and marketing.
However, should IVM products be allowed in principle, a host of policy and regulatory
issues  will  need  thorough  consideration:  Industrial,  labour  and  market  regulations
(production  planning,  land  use,  employment  issues,  IPR  issues,  competition,  etc.);
Production  oversight  (hygiene  standards,  nutrition  standards,  donor  categories,
wellbeing of  cell  donors,  etc.);  Consumer protection (categorising,  labelling,  product
safety,  warnings/endorsements,  etc.).  With  all  that  taken  together,  the  question  still
remains if we want IVM products in the world.
Policy  consideration  (general  for  innovation  policy):  Which  technology  assessment
methodologies can come together to adequately clarify what is at stake in deeply uncertain
early stage technologies and to identify how to constructively move them forward?
With respect to IVM specifically:  We recommend bringing together  a range of technology
assessment methodologies who, in coming together, can map and adequately characterise the
challenges of integrating IVM into the agri-food system.
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